EPISODE · Jul 28, 2023 · 43 MIN
Big Biotech Buyout, Power Players Pt. 2 7/28/23
from Power Lunch · host CNBC
There’s a massive biotech buyout underway, with Biogen paying over $6 billion to bulk up its rare disease portfolio. We’ll explore the “arms race” brewing in big pharma.Plus, we have more ‘power players’ joining the show. Valley Bank’s CEO gives us a read on rising rates and new bank rules, while the Union Square Hospitality Group CEO gives us insight into the consumer. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
There’s a massive biotech buyout underway, with Biogen paying over $6 billion to bulk up its rare disease portfolio. We’ll explore the “arms race” brewing in big pharma. Plus, we have more ‘power players’ joining the show. Valley Bank’s CEO gives us a read on rising rates and new bank rules, while the Union Square Hospitality Group CEO gives us insight into the consumer.
NOW PLAYING
Big Biotech Buyout, Power Players Pt. 2 7/28/23
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·73m
Apr 18, 2026 ·95m
Apr 15, 2026 ·55m
Apr 13, 2026 ·68m
Apr 11, 2026 ·59m
Apr 9, 2026 ·66m